A clinical trial of BioPhage-PR in cystic fibrosis patients with Pseudomonas aeruginosa lung infections.
Phase of Trial: Phase I
Latest Information Update: 18 Sep 2012
At a glance
- Drugs BioPhage PR (Primary)
- Indications Bacterial infections; Cystic fibrosis-associated respiratory tract infections
- Focus Therapeutic Use
- 18 Sep 2012 New trial record